1 – 10 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice
(
- Contribution to journal › Article
-
Mark
RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine
(
- Contribution to journal › Article
- 2023
-
Mark
Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
(
- Contribution to journal › Article
-
Mark
Paradigm Shift in the Management of Metabolic Diseases—Next-Generation Incretin Therapy
(
- Contribution to journal › Scientific review
-
Mark
Anti-Incretin Gut Features Induced by Feed Supplementation with Alpha-Amylase : Studies on EPI Pigs
(
- Contribution to journal › Article
-
Mark
Inclusion of Oat Polar Lipids in a Solid Breakfast Improves Glucose Tolerance, Triglyceridemia, and Gut Hormone Responses Postprandially and after a Standardized Second Meal: A Randomized Crossover Study in Healthy Subjects
(
- Contribution to journal › Article
- 2022
-
Mark
In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system
(
- Contribution to journal › Article
- 2021
-
Mark
The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice : Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice
(
- Contribution to journal › Article
-
Mark
Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
(
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice
(
- Contribution to journal › Article